Investing.com - Gilead (NASDAQ:GILD) reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Gilead announced earnings per share of $1.11 on revenue of $5.07B. Analysts polled by Investing.com anticipated EPS of $1.48 on revenue of $5.32B.
Gilead shares are up 11% from the beginning of the year and are trading at $71.81 , down-from-52-week-high.They are under-performing the Nasdaq which is up 18% from the start of the year.
Gilead shares lost 0.69% in after-hours trade the report.
Gilead follows other major Healthcare sector earnings this month
Gilead's report follows an earnings beat by J&J on Thursday, July 16, 2020, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on Thursday, July 23, 2020 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar